Mamilla, Maria Corazon .

HRN: 17-26-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2025
AMPICILLIN 1GM (VIAL)
07/03/2025
07/10/2025
IV
2g
Q6h
Thickly MSAF
Waiting Final Action 
07/03/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/03/2025
07/10/2025
IV
500mg
Q8H
THICKLY MSAF
Waiting Final Action 
07/03/2025
CEFUROXIME 1.5GM (VIAL)
07/03/2025
07/04/2025
IV
1.5gram
Q8H
S/P LTCS W/ BTL Under SA-GETA
Waiting Final Action 
07/05/2025
CEFUROXIME 500MG (TAB)
07/05/2025
07/12/2025
PO
500mg
BID
S/P CS
Waiting Final Action 
07/05/2025
MUPIROCIN 2%, 15G (TUBE)
07/05/2025
07/12/2025
TOPICAL
15g (2%)
OD
S/P CS
Waiting Final Action 
07/06/2025
METRONIDAZOLE 500MG (TAB)
07/06/2025
07/12/2025
PO
500mg
Tid
Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: